Conference Coverage

New BACE1 study launches in the shadow of verubecestat’s demise

Publish date: November 4, 2017

 

AT CTAD

On Twitter @Alz_Gal

Pages

Recommended Reading

VIDEO: Alzheimer’s blood test expected soon
MDedge Neurology
AF patients without oral anticoagulation face higher dementia risk
MDedge Neurology
Blood Test May Detect Amyloid Plaques in the Brain
MDedge Neurology
Bryostatin Is Safe in Patients With Moderate to Severe Alzheimer’s Disease
MDedge Neurology
Lumateperone shows broad phase 3 potential for psychiatric disorders
MDedge Neurology
Tips for Preventing Encephalitis
MDedge Neurology
Transient Epileptic Amnesia Is Not Associated With Elevated Risk of Alzheimer’s Disease
MDedge Neurology
Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentum
MDedge Neurology
In Lewy body disease, CSF may reveal dementia risk
MDedge Neurology
Aducanumab continues to rack up positive numbers in phase 1b open-label extension
MDedge Neurology